Metabolic bone diseases: Teriparatide or alendronate for glucocorticoid-induced osteoporosis therapy?

被引：0
|
作者：
Nassabeh N.
机构：
来源：
Nature Reviews Rheumatology | 2010年 / 6卷 / 1期
关键词：
D O I：
10.1038/nrrheum.2009.241
中图分类号：
学科分类号：
摘要：
[No abstract available]
引用
收藏
页码：1 / 1
相关论文
共 50 条
  • [41] Teriparatide versus alendronate in glucocorticoid-induced osteoporosis: Results of a subgroup analysis in men, pre- and postmenopausal women
    Langdahl, B.
    Dobnig, H.
    Zanchetta, J. R.
    Maricic, M.
    Krohn, K.
    See, K.
    Marin, F.
    Warner, M. R.
    [J]. CALCIFIED TISSUE INTERNATIONAL, 2008, 82 : S251 - S251
  • [42] An effect comparison of alendronate and teriparatide in patients with glucocorticoid-induced osteoporosis: A protocol for systematic review and meta-analysis
    Liang, Na
    Zhang, Shuang
    Wang, Shuang
    Ma, Juan
    [J]. MEDICINE, 2022, 101 (48) : E32090
  • [43] Consistency of effect of alendronate in glucocorticoid-induced and postmenopausal osteoporosis.
    Ernkey, R
    Saag, K
    Brown, J
    Correa-Rotter, R
    Malice, MP
    Carofano, W
    Dalfotis, A
    [J]. ARTHRITIS AND RHEUMATISM, 1998, 41 (09): : S44 - S44
  • [44] Prevention of glucocorticoid-induced osteoporosis with alendronate compared with alphacalcidol.
    de Nijs, RNJ
    Jacobs, WG
    Algra, A
    Buskens, E
    Huisman, M
    de Laet, CED
    Laan, RFJ
    Lems, WF
    Biljlsma, JWJ
    [J]. ARTHRITIS AND RHEUMATISM, 2004, 50 (09): : S497 - S497
  • [45] Glucocorticoid-induced osteoporosis: pathophysiology and therapy
    E. Canalis
    G. Mazziotti
    A. Giustina
    J. P. Bilezikian
    [J]. Osteoporosis International, 2007, 18 : 1319 - 1328
  • [46] Glucocorticoid-induced osteoporosis: pathophysiology and therapy
    Canalis, E.
    Mazziotti, G.
    Giustina, A.
    Bilezikian, J. P.
    [J]. OSTEOPOROSIS INTERNATIONAL, 2007, 18 (10) : 1319 - 1328
  • [47] Anabolic therapy in glucocorticoid-induced osteoporosis
    Sambrook, Philip N.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2007, 357 (20): : 2084 - 2086
  • [48] TRABECULAR BONE SCORE IN PATIENTS WITH CHRONIC GLUCOCORTICOID OSTEOPOROSIS TREATED WITH ALENDRONATE OR TERIPARATIDE
    Saag, K. G.
    Agnusdei, D.
    Hans, D.
    Kohlmeier, L. A.
    Krohn, K. D.
    Leib, E. S.
    Maclaughlin, E. J.
    See, K.
    Simonelli, C.
    Taylor, K. A.
    Marcus, R.
    [J]. OSTEOPOROSIS INTERNATIONAL, 2015, 26 : S84 - S85
  • [49] Effect of alendronate on glucocorticoid-induced osteoporosis in Japanese women with systemic autoimmune diseases: versus alfacalcidol
    Takeda, Seiji
    Kaneoka, Hidetoshi
    Saito, Takao
    [J]. MODERN RHEUMATOLOGY, 2008, 18 (03) : 271 - 276
  • [50] Glucocorticoid-induced osteoporosis in asthma and respiratory diseases
    Malerba, M
    Romanelli, G
    Grassi, V
    [J]. GLUCOCORTICOID-INDUCED OSTEOPOROSIS, 2002, 30 : 86 - 93
12345